CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment

BACKGROUND: Lung cancer is the leading cause of cancer-related mortality globally. Discovering effective biomarkers for early diagnosis and prognosis is important to reduce the mortality rate and ensure efficient therapy for lung cancer patients. C-type lectin domain family 3 member B (CLEC3B) has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jiaxing, Xie, Tian, Jamal, Muhammad, Tu, Zhenbo, Li, Xinran, Wu, Yingjie, Li, Jingyuan, Zhang, Qiuping, Huang, Xiaoxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110733/
https://www.ncbi.nlm.nih.gov/pubmed/32265595
http://dx.doi.org/10.1186/s12935-020-01183-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110733/
https://www.ncbi.nlm.nih.gov/pubmed/32265595
http://dx.doi.org/10.1186/s12935-020-01183-1

Ejemplares similares